Orex Minerals Inc.TSXV: REX

1st Quarter Report - Jul 31, 2025 FS

· Issued by Orex Minerals Inc.

OREX MINERALS INC.

Condensed Consolidated Interim Financial Statements (Expressed in Canadian Dollars) For the period ended July 31, 2025 Notice to Reader

Under National Instrument 51-102, Part 4, subsection 4.3(3)(a), if an auditor has not performed a review of the condensed consolidated interim financial statements, they must be accompanied by a notice indicating that the condensed consolidated interim financial statements have not been reviewed by an auditor.

The accompanying unaudited condensed consolidated interim financial statements of the Company have been prepared by and are the

responsibility of the Company's management.

The Company's independent auditor has not performed a review of these condensed consolidated interim financial statements in accordance with the standards established by the Chartered Professional Accountants of Canada for a review of financial statements by an entity's auditor.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION

(Expressed in Canadian Dollars)

As at

July 31,

April 30,

2025

2025

ASSETS

Current

Cash

$ 59,183

$ 69,051

Restricted cash

50,000

50,000

Receivables

96,795

93,039

Prepaid expenses and deposits

13,516

5,117

219,494

217,207

Equipment (Note 4)

6,728

7,289

Deposits

25,000

25,000

Investment in associates (Note 6)

2,429,008

2,443,141

IVA receivable

183,834

167,688

Exploration and evaluation assets (Note 5)

1

1

$ 2,864,065

$ 2,860,326

LIABILITIES AND SHAREHOLDERS' EQUITY

Current

Accounts payable and accrued liabilities

$ 637,454

$ 524,376

Shareholders' equity

Share capital (Note 7)

40,664,048

40,213,446

Reserves (Note 7)

7,345,701

7,058,562

Accumulated other comprehensive income

492,154

505,675

Deficit

(46,275,292)

(45,441,733)

2,226,611

2,335,950

$ 2,864,065

$ 2,860,326

Nature and continuance of operations (Note 1)

Approved and authorized by the board on September 29, 2025

"John Eren" Director "Stephen Cope" Director John Eren Stephen Cope

The accompanying notes are an integral part of these condensed consolidated financial statements.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS

(Expressed in Canadian Dollars)

Three months

ended July 31,

Three months

ended July 31

2025

2024

EXPLORATION EXPENSES

Geological (Note 10)

$ -

$ 51,600

General exploration

47,710

59,071

47,710

110,671

GENERAL EXPENSES

Consulting fees

100,253

1,000

Depreciation (Note 4)

561

561

Investor relations

684

16,935

Management fees (Note 10)

37,500

103,200

Office and administrative

56,209

87,370

Professional fees

15,126

15,075

Rent

40,710

4,800

Stock-based compensation

502,181

-

Transfer agent and filing fees

9,202

7,938

762,426

236,879

(810,136)

(347,550)

Dilution gain on investment in associate (Note 6)

-

81,461

Equity loss in associated companies (Note 6)

(46,472)

(122,458)

Foreign exchange gain

23,049

17,816

Gain on settlement of accounts payable

-

43,131

(23,423)

19,950

Loss for the period

(833,559)

(327,600)

Equity investment - foreign currency translation (Note 6)

(13,521)

(136,378)

Comprehensive loss for the period

$ (847,080)

$ (463,978)

Basic and diluted loss per common share

$ (0.02)

$ (0.01)

Weighted average number of common shares outstanding - basic and diluted

35,637,875

24,609,631

The accompanying notes are an integral part of these condensed consolidated financial statements.

Common Shares

Share Capital

Reserves

Accumulated

other comprehensive

income

Deficit

Total

Shareholders'

Equity

Balance, April 30, 2024

19,964,806

$ 37,723,754

$ 6,808,422

$ 548,875

$ (42,138,495)

$ 2,942,556

Issuance of common shares

6,666,617

955,060

44,933

-

-

999,993

Share issuance costs

-

(10,366)

-

-

-

(10,366)

Share-based payments

-

-

265,612

-

-

265,612

Warrant modification

-

(190,988)

190,988

-

-

-

Warrants exercised

6,366,282

1,252,926

(43,333)

-

-

1,209,593

Stock options exercised

1,284,090

483,060

(208,060)

-

-

275,000

Comprehensive loss for the year

-

-

-

(43,200)

(3,303,238)

(3,346,438)

Balance, April 30, 2025

34,281,795

$ 40,213,446

$ 7,058,562

$ 505,675

$ (45,441,733)

$ 2,335,950

Share-based payments

-

-

502,181

-

-

502,181

Stock options exercised

1,938,783

450,602

(215,042)

-

-

235,560

Comprehensive loss for the period

(13,521)

(833,559)

(847,080)

Balance, July 31, 2025

36,220,578

$ 40,664,048

$ 7,345,701

$ 492,154

$ (46,275,272)

$ 2,226,611

The accompanying notes are an integral part of these condensed consolidated financial statements.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS

(Expressed in Canadian Dollars)

Three months

Three month

ended July 31,

ended July

2025

31, 2024

CASH FLOWS FROM OPERATING ACTIVITIES

Loss for the period

$ (833,559)

$ (327,600)

Items not affecting cash:

Depreciation

561

561

Dilution gain on investment in associate

-

(81,461)

Equity loss in associated companies

46,472

122,458

Gain on settlement of accounts payable

-

43,131

Stock-based compensation

502,181

-

Changes in non-cash working capital items:

Receivables

(3,756)

(37,140)

Prepaid expenses

(8,399)

(24,349)

IVA receivable

(16,146)

11,627

Accounts payable and accrued liabilities

183,638

(30,250)

Cash used in operating activities (129,008) (323,023)

CASH FLOWS FROM INVESTING ACTIVITIES

Equity investments (45,860) -

Cash used in investing activities (45,860) -

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from private placement, net share issuance costs - 992,627 Proceeds from exercise of options 165,000 -

Cash from financing activities 165,000 992,627

Change in cash during the period (9,868) 669,604 Cash, beginning of period 69,051 27,907 Cash, end of period $ 59,183 $ 697,511 Supplemental disclosure with respect to cash flows (Note 9)

The accompanying notes are an integral part of these condensed consolidated financial statements.